John L Wallace Selected Research

NCX 1022

11/2004

Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John L Wallace Research Topics

Disease

54	Inflammation (Inflammations) 01/2022 - 08/2002
16	Ulcer 01/2020 - 10/2002
14	Colitis 05/2021 - 09/2003
11	Stomach Ulcer (Gastric Ulcer) 03/2011 - 10/2002
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2021 - 11/2002
8	Hemorrhage 11/2020 - 11/2008
8	Neoplasms (Cancer) 01/2018 - 01/2005
7	Pain (Aches) 10/2021 - 01/2006
7	Edema (Dropsy) 01/2014 - 08/2002
5	Arthritis (Polyarthritis) 01/2018 - 04/2005
4	Hyperalgesia 11/2020 - 07/2006
4	Dysbiosis 06/2015 - 10/2011
3	Weight Loss (Weight Reduction) 01/2020 - 11/2004
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2019 - 09/2010
3	Hypertension (High Blood Pressure) 01/2018 - 04/2006
3	Intestinal Diseases (Diseases, Intestinal) 01/2017 - 09/2003
3	Colonic Neoplasms (Colon Cancer) 09/2014 - 11/2005
3	Hyperplasia 01/2014 - 02/2002
3	Ulcerative Colitis 01/2012 - 11/2002
2	Crohn Disease (Crohn's Disease) 05/2021 - 11/2002
2	Nausea 01/2020 - 01/2008
2	Coinfection 01/2020 - 01/2017
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019 - 01/2008
2	Liver Diseases (Liver Disease) 01/2019 - 02/2002
2	Pathologic Processes 01/2018 - 05/2015
2	Hyperemia 01/2015 - 01/2008
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2014 - 11/2013
2	Aberrant Crypt Foci 09/2014 - 11/2005
2	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 11/2005
2	Osteoarthritis 11/2013 - 03/2009
2	Infections 04/2009 - 12/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2007 - 12/2005
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Dyspepsia (Indigestion) 01/2020
1	Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

33	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 01/2006
20	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 04/2004
12	2-(6-methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl esterIBA 10/2021 - 03/2010
12	Naproxen (Naprosyn)FDA LinkGeneric 10/2021 - 03/2010
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 02/2002
10	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2021 - 10/2002
10	Pharmaceutical PreparationsIBA 01/2019 - 11/2004
8	EnzymesIBA 01/2016 - 02/2006
7	Peptide Hydrolases (Proteases)FDA Link 05/2021 - 11/2002
7	ProstaglandinsIBA 06/2010 - 01/2003
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2015 - 10/2002
6	Celecoxib (Celebrex)FDA Link 01/2012 - 03/2002
6	Acetic Acid (Vinegar)FDA LinkGeneric 03/2011 - 10/2002
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2007 - 05/2002
5	Proteinase-Activated ReceptorsIBA 05/2021 - 08/2002
5	AcidsIBA 05/2021 - 12/2005
5	CytokinesIBA 01/2018 - 10/2007
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2016 - 01/2003
5	CarrageenanIBA 11/2013 - 08/2002
4	HaptensIBA 05/2015 - 11/2004
4	GasotransmittersIBA 05/2015 - 08/2009
4	sodium bisulfide (NaHS)IBA 01/2015 - 01/2006
4	Peptides (Polypeptides)IBA 01/2012 - 08/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2006 - 10/2002
3	Thrombin FDA Link 05/2021 - 08/2002
3	AntioxidantsIBA 01/2019 - 10/2004
3	diallyl disulfide (diallyl disulphide)IBA 05/2015 - 02/2015
3	Sulfonic AcidsIBA 04/2015 - 11/2004
3	Cyclooxygenase InhibitorsIBA 12/2014 - 10/2002
3	LipoxinsIBA 01/2012 - 07/2003
3	Phenobarbital (Luminal)FDA Link 10/2008 - 11/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2008 - 10/2002
3	Adenosine Triphosphate (ATP)IBA 12/2007 - 10/2006
2	Ketoprofen (Orudis)FDA LinkGeneric 11/2020 - 01/2018
2	LyasesIBA 05/2015 - 04/2015
2	CystathionineIBA 05/2015 - 04/2015
2	HydrogenIBA 02/2015 - 02/2010
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015 - 10/2013
2	Cysteine (L-Cysteine)FDA Link 01/2015 - 12/2007
2	AzoxymethaneIBA 09/2014 - 11/2005
2	Drinking WaterIBA 01/2014 - 01/2008
2	EstersIBA 11/2013 - 10/2006
2	Proton Pump InhibitorsIBA 10/2011 - 12/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 11/2004
2	Messenger RNA (mRNA)IBA 08/2009 - 10/2006
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008 - 12/2006
2	GlucocorticoidsIBA 03/2008 - 07/2003
2	Capsaicin (Zostrix)FDA Link 01/2008 - 09/2003
2	nitroaspirinIBA 12/2007 - 01/2004
2	Diclofenac (SR 38)FDA LinkGeneric 01/2007 - 10/2006
2	EndostatinsIBA 06/2006 - 10/2002
2	Irritants (Vesicants)IBA 01/2006 - 11/2004
2	lipoxin A4IBA 11/2004 - 07/2003
2	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2004 - 02/2002
2	(3- 4- (2- fluoromethyl- (1,1'- biphenyl)- 4- acetyloxy)- 3- methoxyphenyl)- 2- propenoic acid 4-nitrooxy butyl esterIBA 05/2004 - 03/2002
1	Dabigatran FDA Link 05/2021
1	Analgesics (Analgesic Drugs)IBA 11/2020
1	NLR ProteinsIBA 01/2020
1	PyrinIBA 01/2020
1	EicosanoidsIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019

Therapy/Procedure

10	Therapeutics 12/2016 - 11/2005
7	Chemoprevention 01/2018 - 10/2013
3	Oral Administration 02/2015 - 09/2004